CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 2.22
  • -0.01-0.45%
Trading May 29 13:10 CST
10.97BMarket Cap-13962P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-33.33%21.19B
7.01%28.15B
4.53%25.63B
50.44%38.15B
19.63%31.78B
13.16%26.31B
11.83%24.52B
11.14%25.36B
-5.31%26.56B
-13.43%23.25B
Transactional financial assets
25.88%1.84B
-13.64%1.8B
-8.27%2.04B
-14.58%1.68B
-32.28%1.46B
-28.38%2.08B
-23.95%2.22B
-26.34%1.97B
-29.59%2.16B
-14.27%2.91B
Notes receivable and accounts receivable
75.34%103.3M
-6.64%77.2M
38.89%71.89M
13.84%84.83M
23.41%58.92M
187.65%82.68M
19.33%51.76M
58.13%74.52M
26.36%47.74M
80.42%28.74M
-Accounts receivable
75.34%103.3M
-6.64%77.2M
38.89%71.89M
13.84%84.83M
23.41%58.92M
187.65%82.68M
19.33%51.76M
58.13%74.52M
26.36%47.74M
80.42%28.74M
Other receivables (including interest and dividends)
11.59%13.95B
28.36%13.76B
30.11%13.19B
183.86%12.35B
21.01%12.5B
33.68%10.72B
36.49%10.14B
-27.46%4.35B
57.74%10.33B
36.97%8.02B
-Accrued interest receivable
22.09%9.49B
36.66%9.48B
18.49%8.7B
--8.07B
34.52%7.78B
37.05%6.94B
30.39%7.34B
----
43.82%5.78B
29.39%5.06B
-Other receivable
--4.46B
13.13%4.28B
--4.49B
-1.76%4.27B
----
27.91%3.78B
----
242.57%4.35B
----
52.24%2.96B
Inventories
-59.58%4.29B
-60.66%4.13B
-63.22%3.95B
2.12%10.81B
0.77%10.63B
2.73%10.5B
-5.55%10.74B
-3.47%10.59B
-1.75%10.54B
-4.59%10.22B
Exceptional items of current assets
----
----
----
----
----
----
----
--6.74B
----
----
Total current assets
-24.86%44.63B
-9.49%50.67B
-7.64%47.4B
26.28%66.54B
11.24%59.4B
11.16%55.98B
7.69%51.32B
13.72%52.69B
0.25%53.39B
-2.68%50.36B
Non Current assets
Held to maturity investments
-98.87%100M
-98.87%100M
-4.29%8.45B
-0.33%8.8B
-1.61%8.83B
-9.52%8.83B
-9.72%8.83B
-9.71%8.83B
48.26%8.98B
75.42%9.76B
Financial assets available for sale
-8.38%108.79B
11.36%125.67B
19.29%130.33B
18.94%121.53B
21.50%118.74B
17.08%112.85B
-4.51%109.25B
-6.63%102.18B
-12.89%97.73B
-8.06%96.39B
Investment real estate
72.76%19.32B
73.96%19.48B
78.30%19.17B
4.88%11.27B
4.25%11.19B
4.42%11.2B
1.33%10.75B
1.55%10.75B
0.64%10.73B
1.90%10.73B
Long-term equity investment
-2.25%9.95B
-2.15%9.92B
-3.85%9.96B
-5.01%9.92B
-0.21%10.18B
0.26%10.14B
3.80%10.36B
11.28%10.44B
15.53%10.2B
14.58%10.11B
Fixed assets
----
----
----
12.87%673.35M
----
6.01%653.36M
----
16.66%596.59M
----
28.91%616.31M
Constru in process
----
----
----
-93.47%6.28M
----
-0.48%95.45M
----
-3.54%96.17M
----
-6.29%95.9M
Intangible assets
-4.97%273.59M
-5.39%283.2M
2.93%272.67M
7.50%279.94M
10.93%287.91M
10.99%299.34M
27.43%264.91M
36.66%260.41M
38.79%259.53M
41.95%269.71M
Goodwill
0.01%6.19B
0.01%6.19B
0.00%6.19B
0.00%6.19B
0.00%6.19B
0.00%6.19B
0.00%6.19B
0.00%6.19B
0.00%6.19B
0.00%6.19B
Deferred tax assets
27.11%2.59B
16.39%2.65B
17.40%2.32B
40.95%2.06B
14.59%2.04B
125.70%2.28B
161.83%1.98B
51.55%1.46B
96.26%1.78B
3.50%1.01B
Usufruct assets
-23.23%64.65M
-21.07%75.19M
-0.85%88.53M
-8.06%90.91M
-22.13%84.21M
-19.35%95.26M
-31.29%89.3M
34.78%98.87M
34.15%108.13M
50.65%118.11M
Other non current assets
23.78%326.5M
12.71%297.87M
7.38%275.56M
30.98%289.49M
-20.85%263.76M
-16.29%264.27M
13.01%256.61M
-42.86%221.02M
-3.67%333.24M
-1.37%315.7M
Total non current assets
-0.95%237.74B
8.02%251.27B
13.45%258.81B
9.88%241.43B
11.53%240.02B
8.93%232.62B
10.18%228.13B
9.59%219.73B
9.82%215.21B
13.75%213.55B
Total assets
-5.69%282.37B
4.62%301.94B
9.57%306.2B
13.05%307.98B
11.47%299.41B
9.36%288.6B
9.71%279.45B
10.36%272.42B
7.78%268.6B
10.20%263.9B
Liabilities
Current liabilities
Notes payable and accounts payable
638.21%635.62M
358.70%949.05M
1,533.30%955.02M
33.97%76.41M
28.41%86.1M
121.26%206.9M
105.15%58.47M
188.68%57.03M
-76.60%67.05M
167.09%93.51M
-Accounts payable
638.21%635.62M
358.70%949.05M
1,533.30%955.02M
33.97%76.41M
28.41%86.1M
121.26%206.9M
105.15%58.47M
188.68%57.03M
-76.60%67.05M
167.09%93.51M
Contract liabilities
-85.28%3.29M
-63.96%3.74M
-58.88%3.13M
-58.05%3.04M
100.77%22.35M
30.70%10.37M
--7.61M
--7.24M
--11.13M
--7.94M
Advance receipts
-22.38%33.11M
-32.39%33.99M
13.49%48.5M
9.48%46.88M
46.27%42.65M
119.23%50.28M
109.47%42.73M
--42.82M
41.27%29.16M
4.82%22.93M
Salaries payable
-42.87%76.81M
-17.31%136.06M
56.14%51.09M
8.20%30.64M
35.45%134.44M
-12.19%164.54M
-59.09%32.72M
-56.37%28.32M
-18.91%99.26M
25.81%187.38M
Taxs payable
-43.83%50.79M
-7.73%78.52M
79.42%73.54M
-15.77%55.58M
39.72%90.43M
-40.29%85.11M
-90.00%40.99M
62.43%65.99M
-43.39%64.72M
117.94%142.54M
Other payable (including interest and dividends)
37.10%1.41B
53.40%1.31B
31.91%1.13B
-71.98%889.19M
-10.72%1.03B
-6.36%851.7M
-41.79%854.2M
222.70%3.17B
87.53%1.15B
73.26%909.58M
-Interest payable
----
----
----
6.53%323.86M
----
40.38%154.62M
----
248.60%304.02M
----
1,368.71%110.14M
-Other payable
----
----
----
----
----
-12.80%697.09M
----
220.18%2.87B
----
54.48%799.44M
Total current liabilities
-1.36%23.54B
-2.10%24.46B
-3.21%22.74B
12.36%25.01B
14.68%23.86B
91.32%24.99B
73.21%23.49B
27.12%22.25B
55.53%20.81B
62.92%13.06B
Current liabilities
Long term loan
30.14%1.7B
24.32%1.59B
92.94%1.47B
114.86%1.41B
103.37%1.3B
119.47%1.28B
52.95%763.9M
110.76%654M
106.45%640.6M
87.70%582.44M
Bonds payable
0.00%5.51B
0.00%5.51B
0.00%5.51B
0.00%5.51B
0.00%5.51B
0.00%5.51B
5.76%5.51B
124.90%5.51B
124.90%5.51B
124.90%5.51B
Deferred tax liabilities
2.32%1.38B
2.27%1.38B
-7.85%1.34B
9.00%1.34B
9.54%1.35B
5.21%1.35B
11.42%1.45B
-12.41%1.23B
-13.70%1.23B
-15.69%1.28B
Lease liabilities
-33.25%54.2M
-20.12%71.56M
2.25%84.99M
-9.29%84.15M
-21.05%81.2M
-19.42%89.58M
-32.86%83.12M
39.83%92.77M
39.31%102.85M
60.41%111.18M
Other non current liabilities
-22.21%77.65M
-36.36%37.36M
-80.54%46.54M
26.37%62.1M
-65.49%99.82M
-27.85%58.7M
200.34%239.17M
-74.33%49.14M
432.88%289.24M
-25.41%81.35M
Exceptional items of non current liabilities
-36.84%35.91B
-2.45%51.02B
23.46%59.68B
26.90%59.25B
24.07%56.86B
16.15%52.3B
10.89%48.34B
13.11%46.69B
12.07%45.83B
10.10%45.03B
Total non current liabilities
-6.24%225.28B
6.48%243.84B
12.97%249.76B
16.31%248.82B
13.26%240.29B
7.33%229.01B
8.38%221.09B
10.32%213.93B
5.81%212.16B
8.38%213.37B
Total liabilities
-5.80%248.82B
5.63%268.3B
11.41%272.5B
15.94%273.83B
13.39%264.15B
12.17%254B
12.42%244.58B
11.71%236.18B
8.92%232.96B
10.52%226.43B
Shareholders equity
Paid-in capital
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
0.00%4.94B
Capital reserve funds
-0.48%11.04B
-0.48%11.04B
-0.48%11.04B
0.00%11.09B
-0.01%11.09B
-0.01%11.09B
-0.02%11.09B
-0.02%11.09B
-0.01%11.09B
-0.01%11.09B
Surplus reserve funds
1.19%277.52M
1.19%277.52M
33.13%274.25M
33.13%274.25M
33.13%274.25M
33.13%274.25M
1.60%206.01M
1.60%206.01M
1.60%206.01M
1.60%206.01M
Retained profit
-20.35%5.22B
-18.41%5.31B
-12.05%5.75B
-10.82%5.78B
1.22%6.55B
2.86%6.51B
5.28%6.54B
4.92%6.48B
5.56%6.47B
7.07%6.33B
Other composite income
16.39%-932.42M
30.34%-978.79M
11.08%-1.38B
-47.39%-1.18B
-1.84%-1.12B
-9,203.10%-1.41B
-2,212.00%-1.56B
12.85%-798.51M
-27.50%-1.1B
98.51%-15.1M
Shareholders equity without minority interests
-5.52%20.55B
-3.84%20.59B
-2.83%20.62B
-4.61%20.91B
0.58%21.75B
-5.06%21.41B
-5.18%21.22B
1.97%21.92B
0.50%21.62B
6.71%22.55B
Minority interests
-3.78%13.01B
-1.12%13.04B
-4.13%13.08B
-7.52%13.24B
-3.56%13.52B
-11.60%13.19B
-7.56%13.64B
2.85%14.32B
1.50%14.02B
10.91%14.92B
Total shareholder equity
-4.85%33.55B
-2.80%33.63B
-3.34%33.7B
-5.76%34.15B
-1.05%35.26B
-7.66%34.6B
-6.13%34.87B
2.32%36.24B
0.89%35.64B
8.35%37.47B
Total liabilityies and equity
-5.69%282.37B
4.62%301.94B
9.57%306.2B
13.05%307.98B
11.47%299.41B
9.36%288.6B
9.71%279.45B
10.36%272.42B
7.78%268.6B
10.20%263.9B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -33.33%21.19B7.01%28.15B4.53%25.63B50.44%38.15B19.63%31.78B13.16%26.31B11.83%24.52B11.14%25.36B-5.31%26.56B-13.43%23.25B
Transactional financial assets 25.88%1.84B-13.64%1.8B-8.27%2.04B-14.58%1.68B-32.28%1.46B-28.38%2.08B-23.95%2.22B-26.34%1.97B-29.59%2.16B-14.27%2.91B
Notes receivable and accounts receivable 75.34%103.3M-6.64%77.2M38.89%71.89M13.84%84.83M23.41%58.92M187.65%82.68M19.33%51.76M58.13%74.52M26.36%47.74M80.42%28.74M
-Accounts receivable 75.34%103.3M-6.64%77.2M38.89%71.89M13.84%84.83M23.41%58.92M187.65%82.68M19.33%51.76M58.13%74.52M26.36%47.74M80.42%28.74M
Other receivables (including interest and dividends) 11.59%13.95B28.36%13.76B30.11%13.19B183.86%12.35B21.01%12.5B33.68%10.72B36.49%10.14B-27.46%4.35B57.74%10.33B36.97%8.02B
-Accrued interest receivable 22.09%9.49B36.66%9.48B18.49%8.7B--8.07B34.52%7.78B37.05%6.94B30.39%7.34B----43.82%5.78B29.39%5.06B
-Other receivable --4.46B13.13%4.28B--4.49B-1.76%4.27B----27.91%3.78B----242.57%4.35B----52.24%2.96B
Inventories -59.58%4.29B-60.66%4.13B-63.22%3.95B2.12%10.81B0.77%10.63B2.73%10.5B-5.55%10.74B-3.47%10.59B-1.75%10.54B-4.59%10.22B
Exceptional items of current assets ------------------------------6.74B--------
Total current assets -24.86%44.63B-9.49%50.67B-7.64%47.4B26.28%66.54B11.24%59.4B11.16%55.98B7.69%51.32B13.72%52.69B0.25%53.39B-2.68%50.36B
Non Current assets
Held to maturity investments -98.87%100M-98.87%100M-4.29%8.45B-0.33%8.8B-1.61%8.83B-9.52%8.83B-9.72%8.83B-9.71%8.83B48.26%8.98B75.42%9.76B
Financial assets available for sale -8.38%108.79B11.36%125.67B19.29%130.33B18.94%121.53B21.50%118.74B17.08%112.85B-4.51%109.25B-6.63%102.18B-12.89%97.73B-8.06%96.39B
Investment real estate 72.76%19.32B73.96%19.48B78.30%19.17B4.88%11.27B4.25%11.19B4.42%11.2B1.33%10.75B1.55%10.75B0.64%10.73B1.90%10.73B
Long-term equity investment -2.25%9.95B-2.15%9.92B-3.85%9.96B-5.01%9.92B-0.21%10.18B0.26%10.14B3.80%10.36B11.28%10.44B15.53%10.2B14.58%10.11B
Fixed assets ------------12.87%673.35M----6.01%653.36M----16.66%596.59M----28.91%616.31M
Constru in process -------------93.47%6.28M-----0.48%95.45M-----3.54%96.17M-----6.29%95.9M
Intangible assets -4.97%273.59M-5.39%283.2M2.93%272.67M7.50%279.94M10.93%287.91M10.99%299.34M27.43%264.91M36.66%260.41M38.79%259.53M41.95%269.71M
Goodwill 0.01%6.19B0.01%6.19B0.00%6.19B0.00%6.19B0.00%6.19B0.00%6.19B0.00%6.19B0.00%6.19B0.00%6.19B0.00%6.19B
Deferred tax assets 27.11%2.59B16.39%2.65B17.40%2.32B40.95%2.06B14.59%2.04B125.70%2.28B161.83%1.98B51.55%1.46B96.26%1.78B3.50%1.01B
Usufruct assets -23.23%64.65M-21.07%75.19M-0.85%88.53M-8.06%90.91M-22.13%84.21M-19.35%95.26M-31.29%89.3M34.78%98.87M34.15%108.13M50.65%118.11M
Other non current assets 23.78%326.5M12.71%297.87M7.38%275.56M30.98%289.49M-20.85%263.76M-16.29%264.27M13.01%256.61M-42.86%221.02M-3.67%333.24M-1.37%315.7M
Total non current assets -0.95%237.74B8.02%251.27B13.45%258.81B9.88%241.43B11.53%240.02B8.93%232.62B10.18%228.13B9.59%219.73B9.82%215.21B13.75%213.55B
Total assets -5.69%282.37B4.62%301.94B9.57%306.2B13.05%307.98B11.47%299.41B9.36%288.6B9.71%279.45B10.36%272.42B7.78%268.6B10.20%263.9B
Liabilities
Current liabilities
Notes payable and accounts payable 638.21%635.62M358.70%949.05M1,533.30%955.02M33.97%76.41M28.41%86.1M121.26%206.9M105.15%58.47M188.68%57.03M-76.60%67.05M167.09%93.51M
-Accounts payable 638.21%635.62M358.70%949.05M1,533.30%955.02M33.97%76.41M28.41%86.1M121.26%206.9M105.15%58.47M188.68%57.03M-76.60%67.05M167.09%93.51M
Contract liabilities -85.28%3.29M-63.96%3.74M-58.88%3.13M-58.05%3.04M100.77%22.35M30.70%10.37M--7.61M--7.24M--11.13M--7.94M
Advance receipts -22.38%33.11M-32.39%33.99M13.49%48.5M9.48%46.88M46.27%42.65M119.23%50.28M109.47%42.73M--42.82M41.27%29.16M4.82%22.93M
Salaries payable -42.87%76.81M-17.31%136.06M56.14%51.09M8.20%30.64M35.45%134.44M-12.19%164.54M-59.09%32.72M-56.37%28.32M-18.91%99.26M25.81%187.38M
Taxs payable -43.83%50.79M-7.73%78.52M79.42%73.54M-15.77%55.58M39.72%90.43M-40.29%85.11M-90.00%40.99M62.43%65.99M-43.39%64.72M117.94%142.54M
Other payable (including interest and dividends) 37.10%1.41B53.40%1.31B31.91%1.13B-71.98%889.19M-10.72%1.03B-6.36%851.7M-41.79%854.2M222.70%3.17B87.53%1.15B73.26%909.58M
-Interest payable ------------6.53%323.86M----40.38%154.62M----248.60%304.02M----1,368.71%110.14M
-Other payable ---------------------12.80%697.09M----220.18%2.87B----54.48%799.44M
Total current liabilities -1.36%23.54B-2.10%24.46B-3.21%22.74B12.36%25.01B14.68%23.86B91.32%24.99B73.21%23.49B27.12%22.25B55.53%20.81B62.92%13.06B
Current liabilities
Long term loan 30.14%1.7B24.32%1.59B92.94%1.47B114.86%1.41B103.37%1.3B119.47%1.28B52.95%763.9M110.76%654M106.45%640.6M87.70%582.44M
Bonds payable 0.00%5.51B0.00%5.51B0.00%5.51B0.00%5.51B0.00%5.51B0.00%5.51B5.76%5.51B124.90%5.51B124.90%5.51B124.90%5.51B
Deferred tax liabilities 2.32%1.38B2.27%1.38B-7.85%1.34B9.00%1.34B9.54%1.35B5.21%1.35B11.42%1.45B-12.41%1.23B-13.70%1.23B-15.69%1.28B
Lease liabilities -33.25%54.2M-20.12%71.56M2.25%84.99M-9.29%84.15M-21.05%81.2M-19.42%89.58M-32.86%83.12M39.83%92.77M39.31%102.85M60.41%111.18M
Other non current liabilities -22.21%77.65M-36.36%37.36M-80.54%46.54M26.37%62.1M-65.49%99.82M-27.85%58.7M200.34%239.17M-74.33%49.14M432.88%289.24M-25.41%81.35M
Exceptional items of non current liabilities -36.84%35.91B-2.45%51.02B23.46%59.68B26.90%59.25B24.07%56.86B16.15%52.3B10.89%48.34B13.11%46.69B12.07%45.83B10.10%45.03B
Total non current liabilities -6.24%225.28B6.48%243.84B12.97%249.76B16.31%248.82B13.26%240.29B7.33%229.01B8.38%221.09B10.32%213.93B5.81%212.16B8.38%213.37B
Total liabilities -5.80%248.82B5.63%268.3B11.41%272.5B15.94%273.83B13.39%264.15B12.17%254B12.42%244.58B11.71%236.18B8.92%232.96B10.52%226.43B
Shareholders equity
Paid-in capital 0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B0.00%4.94B
Capital reserve funds -0.48%11.04B-0.48%11.04B-0.48%11.04B0.00%11.09B-0.01%11.09B-0.01%11.09B-0.02%11.09B-0.02%11.09B-0.01%11.09B-0.01%11.09B
Surplus reserve funds 1.19%277.52M1.19%277.52M33.13%274.25M33.13%274.25M33.13%274.25M33.13%274.25M1.60%206.01M1.60%206.01M1.60%206.01M1.60%206.01M
Retained profit -20.35%5.22B-18.41%5.31B-12.05%5.75B-10.82%5.78B1.22%6.55B2.86%6.51B5.28%6.54B4.92%6.48B5.56%6.47B7.07%6.33B
Other composite income 16.39%-932.42M30.34%-978.79M11.08%-1.38B-47.39%-1.18B-1.84%-1.12B-9,203.10%-1.41B-2,212.00%-1.56B12.85%-798.51M-27.50%-1.1B98.51%-15.1M
Shareholders equity without minority interests -5.52%20.55B-3.84%20.59B-2.83%20.62B-4.61%20.91B0.58%21.75B-5.06%21.41B-5.18%21.22B1.97%21.92B0.50%21.62B6.71%22.55B
Minority interests -3.78%13.01B-1.12%13.04B-4.13%13.08B-7.52%13.24B-3.56%13.52B-11.60%13.19B-7.56%13.64B2.85%14.32B1.50%14.02B10.91%14.92B
Total shareholder equity -4.85%33.55B-2.80%33.63B-3.34%33.7B-5.76%34.15B-1.05%35.26B-7.66%34.6B-6.13%34.87B2.32%36.24B0.89%35.64B8.35%37.47B
Total liabilityies and equity -5.69%282.37B4.62%301.94B9.57%306.2B13.05%307.98B11.47%299.41B9.36%288.6B9.71%279.45B10.36%272.42B7.78%268.6B10.20%263.9B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --China Audit Asia Pacific Certified Public Accountants (Special General Partnership)------China Audit Asia Pacific Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg